10 Jun 2003

UCB : Profits for 2003 essentially affected by the fall in the dollar.

Read More
9 May 2003

UCB Inaugurates North American Pharma Headquarters.

Read More
22 Apr 2003

UCB: First quarter Zyrtec sales in the US.

Read More
1 Apr 2003

Data analysis shows Keppra® reduced partial seizures in nearly 80 percent of elderly patients in a community-based trial.

Read More
14 Mar 2003

UCB Group : confirmation of an increase in ordinary profits of 7%.

Read More
26 Feb 2003

Celltech Group PLC (CCH) - Offer for Oxford GlycoScience

Read More
6 Feb 2003

The UCB Group in 2002: Preliminary Unaudited Profits. Record Ordinary Profits before Tax of € 494 million, an increase of 7%

Read More
31 Jan 2003

UCB closes on its acquisition of Solutia's Resins, Additives and Adhesives businesses

Read More
22 Jan 2003

UCB : Fourth quarter year-to-date Zyrtec sales in the US increase by 13%.

Read More
14 Jan 2003

UCB: Acquisition in the field of Specialty Chemicals

Read More
Subscribe to